Palo Alto, CA2 Active Studies

Peripheral Artery Disease Clinical Trials in Palo Alto, CA

Find 2 actively recruiting peripheral artery disease clinical trials in Palo Alto, CA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
525
Enrolling

Recruiting Peripheral Artery Disease Studies in Palo Alto

About Peripheral Artery Disease Clinical Trials in Palo Alto

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 2 peripheral artery disease clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 525 participants. Research is being sponsored by Palo Alto Veterans Institute for Research, VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Palo Alto — FAQ

Are there peripheral artery disease clinical trials in Palo Alto?

Yes, there are 2 peripheral artery disease clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 17, 2026 from ClinicalTrials.gov